← Search

Data · dataset · 2026

Premature vascular senescence during diabetic retinopathy

Listed in DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.17034/32629749.v1

Cellular senescence is the permanent state of growth arrest with significant phenotypic changes including the senescence-associated secretory phenotype (SASP) and triggered by mechanisms such as telomere shortening and DNA damage.

Description

Diabetes is associated with endothelial dysfunction, which is characterised by increased vascular permeability, deficit in blood perfusion, vessel loss and increased inflammation. Cellular senescence has been implicated in the pathogenesis of diabetes; however, a role for cellular senescence in diabetic retinopathy is unclear.

Therefore, the aim of this study is to investigate the senescence profile of human retinal microvascular endothelial cells (HRMECs), to elucidate how this is affected by the diabetic milieu. <br><br>HRMECs undergo replicative senescence in vitro and they acquire gene and protein expression profiles that are characteristic of a senescent phenotype. Senescent HRMECs show a SASP signature, changes in organelle profiles, loss of endothelial function and metabolic impairment. <br><br>Chronic exposure to high glucose (25mM D-glucose) induces premature senescence in HRMECs.

Read the rest (2 more)

The accelerated senescence programme was characterised by enlarged cellular and nuclear size, upregulation of p53 and CCL2 (MCP1), increased mitochondrial mass but, with alterations in mitochondrial cristae ultrastructure and decreased cellular bioenergetics both glycolysis and oxidative respiration. <br><br>The aged mouse retina shows cellular senescence, accompanied by visual dysfunction and structural changes. The diabetic milieu, both hyperglycaemia and ischaemia, lead to accumulation of senescent cells in the retina, including the retinal vasculature. <br><br>Senolytic drugs are investigated as a therapeutic approach for elimination of senescent HRMECs.

Navitoclax was found to be an effective senolytic for HRMECs<i> in vitro</i>.

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 2 source records, 6 field assertions
SourceKeyLast seenRaw
DMU Figshareoai:figshare.com:article/3262974913 d agoJSON v1
UCL Research Data Repositoryoai:figshare.com:article/3262974913 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
descriptionsource · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0/metadata/dc/description
license_textsource · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
publication_datesource · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
titlesource · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0/metadata/dc/title